Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer-A New Strategy for Prostate Cancer Prevention

NCT03789253 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03789253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03789253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer-A New Strategy for Prostate Cancer Prevention
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2019
Completion date
July 31, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer stage i